| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 151.91B | 158.60B | 149.90B | 137.59B | 137.48B | 121.84B |
| Gross Profit | 14.68B | 15.41B | 14.66B | 13.37B | 13.16B | 12.51B |
| EBITDA | 5.43B | 5.68B | 5.58B | 4.74B | 4.26B | 4.16B |
| Net Income | 2.71B | 2.94B | 2.90B | 2.13B | 1.39B | 1.15B |
Balance Sheet | ||||||
| Total Assets | 76.42B | 83.12B | 74.76B | 78.42B | 73.29B | 71.61B |
| Cash, Cash Equivalents and Short-Term Investments | 6.08B | 7.41B | 5.53B | 7.11B | 8.36B | 7.54B |
| Total Debt | 21.09B | 22.68B | 20.30B | 25.41B | 28.84B | 25.45B |
| Total Liabilities | 42.41B | 44.63B | 40.95B | 47.41B | 47.17B | 42.58B |
| Stockholders Equity | 32.27B | 36.64B | 32.04B | 29.33B | 24.48B | 24.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.15B | 3.41B | 3.12B | 2.62B | -2.66B |
| Operating Cash Flow | 0.00 | 70.00M | 3.92B | 3.59B | 3.34B | -814.00M |
| Investing Cash Flow | 0.00 | -656.00M | 397.00M | -637.00M | -666.00M | -795.00M |
| Financing Cash Flow | 0.00 | 2.46B | -5.89B | -4.21B | -1.86B | -453.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | ¥26.23B | 10.33 | ― | 3.23% | 0.38% | -41.74% | |
64 Neutral | ¥27.03B | 12.47 | ― | 1.94% | 2.71% | 10.31% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥51.04B | 78.54 | ― | 0.52% | -1.79% | 27.43% | |
60 Neutral | ¥13.98B | 16.75 | ― | 3.17% | 5.80% | 1.52% | |
57 Neutral | ¥8.58B | 22.91 | ― | 0.95% | 8.07% | 35.89% |